NCI (National Cancer Institute)
Scientific/Medical - Clinical Care
Group Awards
ASPS Trial Group
For the first trial of immunotherapy in children and adults with Alveolar Soft Part Sarcoma, leading full FDA approval for the therapy in December 2022.
An official website of the
NIH Office of Human Resources